Trials Sponsors Conditions Drugs Pricing

Conditions

Therapeutic Plasma Exchange

Keywords

TPEtherapeutic plasma exchangeSide Effects

Outcome Measures

Primary Outcomes (1)

Frequency of side effects during Therapeutic plasma exchange
Occurrence of side effects, regardless of their severity during therapeutic plasma exchange sessions (From start of care by the nurse including the preparation for the insertion of peripheral or central venous access to disconnection from the device and removal of peripheral lines or closing the CVC),. Main side effects recorded are hypotension, tachycardia, shock, anaphylaxis, seizure, cardiac arrest, respiratory failure, skin rash, urticaria, catheter dysfunction, catheter related infection hypocalcemia, alkalosis.
The inclusion day (retrospective study)

Interventions

Therapeutic plasma exchange (TPE)Device

All TPEs were performed by the centrifugation technique using the Fresenius Kabi COMTEC machine

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

All adult patients who underwent TPE in Rennes University Hospital 2011-2018

You may qualify if:

All adult patients who underwent TPE in Rennes University Hospital 2011-2018

You may not qualify if:

Sponsors & Collaborators

Rennes University Hospital
Otherlead

Study Sites (1)

Centre Hospitalier Universitaire de Rennes

Rennes, 35033, France

Related Publications (1)

Coirier V, Lesouhaitier M, Reizine F, Painvin B, Quelven Q, Maamar A, Gacouin A, Tadie JM, Le Tulzo Y, Camus C. Tolerance and complications of therapeutic plasma exchange by centrifugation: A single center experience. J Clin Apher. 2022 Feb;37(1):54-64. doi: 10.1002/jca.21950. Epub 2021 Nov 17.
PMID: 34786746DERIVED

MeSH Terms

Interventions

Plasma Exchange

Intervention Hierarchy (Ancestors)

Blood TransfusionBiological TherapyTherapeuticsPlasmapheresisBlood Component RemovalSorption DetoxificationExtracorporeal CirculationSurgical Procedures, Operative

Study Officials

Christophe CAMUS, MD
Rennes University Hospital
PRINCIPAL INVESTIGATOR

Enrollment

190 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: RETROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

March 14, 2019

First Posted

March 25, 2019

Study Start

August 15, 2018

Actual (reported)

TPE in Rennes Hospital

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Publications (1)

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Publications (1)

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations